U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07911501) titled 'Perioperative Dutasteride for Hemorrhage Control in Bipolar TURP Under Anticoagulation.' on Oct. 21.
Brief Summary: A prospective, randomized, double-blinded controlled trial to evaluate the efficacy of a 2-week preoperative and 2-week postoperative course of oral dutasteride (0.5 mg daily) in reducing perioperative blood loss, irrigation requirements, and catheterization time in patients on anticoagulant therapy undergoing bipolar TURP for benign prostatic hyperplasia (BPH).
Study Start Date: Oct. 21
Study Type: INTERVENTIONAL
Condition:
Benign Prostatic Hyperplasia
Postoperative Hemorrhage
Perioperative Hemorrhage Control Durin...